## Proton Pump Inhibitor Pharmacology ### Omeprazole as a Prodrug **Key Point:** Omeprazole is a benzimidazole prodrug that requires activation in the acidic environment of the parietal cell canaliculus. It is converted to its active sulfenamide form only at pH < 4, making it selective for the proton pump. ### Metabolism and Drug Interactions **High-Yield:** Omeprazole is metabolized extensively by CYP2C19, making it prone to significant drug interactions. Patients who are poor metabolizers of CYP2C19 may have elevated drug levels and increased adverse effects. ### Comparison of PPIs | PPI | Prodrug Activation | Primary Metabolism | CYP2C19 Dependency | Clinical Note | | --- | --- | --- | --- | --- | | Omeprazole | Yes (pH-dependent) | CYP2C19 (major) | High | Most drug interactions | | Pantoprazole | Yes (pH-dependent) | CYP2C19 (minor) | Low | Fewer interactions | | Rabeprazole | Yes (pH-dependent) | Non-enzymatic | Minimal | Least interactions | | Lansoprazole | Yes (pH-dependent) | CYP2C19, CYP3A4 | Moderate | Intermediate interactions | **Clinical Pearl:** Among all PPIs, omeprazole has the highest potential for CYP2C19-mediated drug interactions, which is clinically significant when co-administered with drugs like clopidogrel, warfarin, or diazepam. ### Mechanism of Activation All PPIs are prodrugs, but omeprazole's activation is particularly dependent on the acidic environment. The protonated form accumulates in the canaliculus and rearranges to form the active sulfenamide, which covalently binds to the H⁺/K⁺-ATPase.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.